EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Quercetin, the primary active component of Uncaria Rhynchophylla, alleviates atopic dermatitis through the PPARD pathway: Integrating network pharmacology prediction and experimental validation

Qing Wu, Dacan Chen, Junfeng Liu, Wei Zhao, Xiaowen Wen, Kaibo Zhang, Yongyi Yan

Letters in Drug Design & Discovery · 2026-09 · 23 (9) · 100591

DOI: 10.1016/j.lddd.2026.100591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-09. Verfasst von Qing Wu und 6 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Basic Research Program of Shaanxi Province, Natural Science Foundation for Young Scientists of Shanxi Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Natural Science Basic Research Program of Shaanxi Province
  • Natural Science Foundation for Young Scientists of Shanxi Province

Zitieren

APA

Wu, Q., Chen, D., Liu, J., Zhao, W., Wen, X., Zhang, K., & Yan, Y. (2026). Quercetin, the primary active component of Uncaria Rhynchophylla, alleviates atopic dermatitis through the PPARD pathway: Integrating network pharmacology prediction and experimental validation. Letters in Drug Design & Discovery, 23(9), 100591. https://doi.org/10.1016/j.lddd.2026.100591

Vancouver

Wu Q, Chen D, Liu J, Zhao W, Wen X, Zhang K, et al. Quercetin, the primary active component of Uncaria Rhynchophylla, alleviates atopic dermatitis through the PPARD pathway: Integrating network pharmacology prediction and experimental validation. Letters in Drug Design & Discovery. 2026;23(9):100591. doi:10.1016/j.lddd.2026.100591

BibTeX
@article{Wu2026,
  author = {Wu, Qing and Chen, Dacan and Liu, Junfeng and Zhao, Wei and Wen, Xiaowen and Zhang, Kaibo and Yan, Yongyi},
  title = {Quercetin, the primary active component of Uncaria Rhynchophylla, alleviates atopic dermatitis through the PPARD pathway: Integrating network pharmacology prediction and experimental validation},
  journal = {Letters in Drug Design & Discovery},
  year = {2026},
  volume = {23},
  number = {9},
  pages = {100591},
  doi = {10.1016/j.lddd.2026.100591}
}
Kostenlos starten →